{"pageContent": "Background: Evolution of cryotherapy for prostate cancer is likely to result in parenchyma-sparing modifications adjacent to the urethra and neurovascular bundle. Results of initial series of focal therapy to minimize cryosurgery-related morbidity without compromising oncologic control have been encouraging, but limited in short-term outcomes.", "metaData": {"source": "Recent Advances in Prostate-Specific Membrane Antigen-Based Radiopharmaceuticals\nhttps://pubmed.ncbi.nlm.nih.gov/30706785/"}}